KCL Gene Therapy Vector Facility completed
Delivered within a live environment, the expanded £5.8 m facility will now operate as one of the largest suppliers of Good Manufacturing Practices (GMP) grade viral vectors, supporting clinical trials across Europe. Its new micro laboratory will be used for routine environmental monitoring activities and assessment of incoming microbiological media. Meanwhile, two laboratories on the